These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37242150)

  • 41. Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.
    Houston J; Smith K; Isakova T; Sowden N; Wolf M; Gutiérrez OM
    J Ren Nutr; 2013 Jan; 23(1):12-20. PubMed ID: 22406119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
    Ho LT; Lin FJ; Tseng WK; Yin WH; Wu YW; Li YH; Yeh HI; Chen JW; Wu CC;
    J Formos Med Assoc; 2018 Sep; 117(9):814-824. PubMed ID: 29945742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.
    Holm Nielsen S; Guldager Kring Rasmussen D; Brix S; Fenton A; Jesky M; Ferro CJ; Karsdal M; Genovese F; Cockwell P
    PLoS One; 2018; 13(10):e0204239. PubMed ID: 30273365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of the serum albumin level with prognosis in chronic kidney disease patients.
    Song H; Wei C; Hu H; Wan Q
    Int Urol Nephrol; 2022 Sep; 54(9):2421-2431. PubMed ID: 35230608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease.
    Kim JH; Han JM; Kim H; Lee KB; Chung W; Kim YS; Park SK; Chae DW; Ahn C; Oh KH; Hyun YY;
    Sci Rep; 2021 May; 11(1):10928. PubMed ID: 34035377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
    Kim H; Park JT; Lee J; Jung JY; Lee KB; Kim YH; Yoo TH; Kang SW; Choi KH; Oh KH; Ahn C; Han SH;
    Atherosclerosis; 2021 Oct; 335():53-61. PubMed ID: 34571286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.
    Mills KT; Chen J; Yang W; Appel LJ; Kusek JW; Alper A; Delafontaine P; Keane MG; Mohler E; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Steigerwalt S; Townsend R; He J;
    JAMA; 2016 May 24-31; 315(20):2200-10. PubMed ID: 27218629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammation and nutritional status assessment by malnutrition inflammation score and its outcome in pre-dialysis chronic kidney disease patients.
    Jagadeswaran D; Indhumathi E; Hemamalini AJ; Sivakumar V; Soundararajan P; Jayakumar M
    Clin Nutr; 2019 Feb; 38(1):341-347. PubMed ID: 29398341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between carbohydrate-to-fat intake ratio and the development of chronic kidney disease: A community-based prospective cohort study.
    Kim H; Lee H; Kwon SH; Jeon JS; Noh H; Han DC; Kim H
    Clin Nutr; 2021 Oct; 40(10):5346-5354. PubMed ID: 34555715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD.
    Jung CY; Heo GY; Park JT; Joo YS; Kim HW; Lim H; Chang TI; Kang EW; Yoo TH; Kang SW; Lee J; Kim SW; Oh YK; Jung JY; Oh KH; Ahn C; Han SH
    Clin Res Cardiol; 2021 Jul; 110(7):1116-1127. PubMed ID: 34003323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study.
    Yoon CY; Park JT; Jhee JH; Noh J; Kee YK; Seo C; Lee M; Cha MU; Kim H; Park S; Yun HR; Jung SY; Han SH; Yoo TH; Kang SW
    Am J Clin Nutr; 2017 Jul; 106(1):311-321. PubMed ID: 28592606
    [No Abstract]   [Full Text] [Related]  

  • 54. Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome.
    Batra G; Ghukasyan Lakic T; Lindbäck J; Held C; White HD; Stewart RAH; Koenig W; Cannon CP; Budaj A; Hagström E; Siegbahn A; Wallentin L;
    JAMA Cardiol; 2021 Dec; 6(12):1440-1445. PubMed ID: 34431970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study.
    Kawasaki T; Maeda Y; Matsuki H; Matsumoto Y; Akazawa M; Kuyama T
    BMC Nephrol; 2015 Jul; 16():116. PubMed ID: 26215643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study.
    Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Oh KH; Han SH; Ma SK; Kim SW
    Front Nutr; 2022; 9():1037618. PubMed ID: 36505239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes.
    Pluquet M; Kamel S; Alencar de Pinho N; Mansencal N; Combe C; Metzger M; Massy ZA; Liabeuf S; Laville SM
    Clin Kidney J; 2024 Apr; 17(4):sfae046. PubMed ID: 38572502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.